We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1138:HKEXDgenx Co., Ltd. Analysis

Data as of 2026-06-19 - not real-time

₩532.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Dgenx Co., Ltd. (1138) is trading at KRW 532, well below its discounted cash‑flow fair value of KRW 1,234, implying a substantial discount of over 50%. The stock sits under the 20‑day (601.55), 50‑day (673.58) and 200‑day (771.65) simple moving averages, confirming a bearish technical backdrop. Momentum indicators are weak, with the RSI at 36.6 (near oversold) and a bearish MACD histogram of -3.39. Volume is on a decreasing trend and 30‑day volatility exceeds 100%, suggesting heightened price swings and limited liquidity support. Fundamentally, the company posts modest revenue growth of 8.7% but thin profit margins (gross 11.3%, operating 5.8%, net 0.8%) and a low ROE of 2.15%. Its price‑to‑sales ratio of 0.21 is attractive, yet a debt‑to‑equity ratio of 59.6% raises balance‑sheet concerns.
Given the pronounced valuation gap and solid cash generation (free cash flow ~KRW 2.2 bn), the stock could reward patient investors, but the current bearish trend, high volatility and weakening liquidity warrant caution. A cautious stance in the short term, transitioning to a more bullish view over medium and long horizons, aligns with the data.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish technical positioning below all major SMAs
  • Decreasing volume and high short‑term volatility
  • Proximity to near‑term support at KRW 506

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation discount to DCF fair value
  • Attractive price‑to‑sales multiple
  • Improving cash flow relative to debt levels

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑run upside potential from undervaluation
  • Stable revenue growth in auto‑parts segment
  • Fundamental resilience despite cyclical sector exposure

Key Metrics & Analysis

Financial Health

Revenue Growth8.70%
Profit Margin0.84%
ROE2.15%
ROA0.36%
Debt/Equity59.63
Op. Cash Flow₩4.3B
Free Cash Flow₩2.2B

Technical Analysis

TrendBearish
RSI36.6
Support₩506.00
Resistance₩800.00
MA 20₩601.55
MA 50₩673.58
MA 200₩771.65
MACDBearish
VolumeDecreasing
Fear & Greed Index91.27

Valuation

Fair Value₩1,233.72
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.02
Volatility101.31%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.